Shin-Ichiro Maehara
Overview
Explore the profile of Shin-Ichiro Maehara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimura K, Adachi E, Toyohara A, Omori S, Ezaki K, Ihara R, et al.
World J Clin Cases
. 2021 Sep;
9(24):7224-7230.
PMID: 34540982
Background: Chronic pancreatitis occasionally requires surgical treatment that can be performed with various techniques. Often, this type of surgery presents with postoperative complications. We report a case of a successful...
2.
Kimura K, Adachi E, Toyohara A, Omori S, Ezaki K, Ihara R, et al.
World J Clin Cases
. 2021 Jun;
9(17):4453-4459.
PMID: 34141813
Background: Schwannoma of the pancreas is extremely rare. We report a case of pancreatic schwannoma that was difficult to distinguish from pancreatic carcinoma before surgery. Case Summary: A 66-year-old male...
3.
Kimura K, Adachi E, Omori S, Toyohara A, Higashi T, Ohgaki K, et al.
BMC Gastroenterol
. 2021 May;
21(1):226.
PMID: 34011273
Background: Percutaneous transhepatic gallbladder drainage (PTGBD) is recommended for acute cholecystitis patients at high risk for surgical treatment. However, there is no evidence about the best timing of surgery after...
4.
Nakanishi R, Takahashi I, Kajiwara Y, Motomura T, Fujinaka Y, Maehara S, et al.
Int Cancer Conf J
. 2019 Jun;
5(1):20-25.
PMID: 31149417
Total pelvic exenteration is often selected for advanced rectal cancer with prostatic invasion. The aim of this study was to evaluate the short term feasibility of the abdominoperineal resection with...
5.
Wang Y, Kuramitsu Y, Baron B, Kitagawa T, Tokuda K, Akada J, et al.
Int J Oncol
. 2016 Dec;
50(2):606-612.
PMID: 28000865
LY294002 and wortmannin are chemical compounds that act as potent inhibitors of phosphoinositide 3-kinases (PI3Ks). Both of them are generally used to inhibit cell proliferation as cancer treatment by inhibiting...
6.
Nakanishi R, Takahashi I, Kajiwara Y, Motomura T, Fujinaka Y, Maehara S, et al.
Fukuoka Igaku Zasshi
. 2015 Dec;
106(8):240-6.
PMID: 26630842
Introduction: Laparoscopic resection has been reported as reasonable for patients with gastrointestinal stromal tumors (GISTs). In this study, we report the feasibility of the laparoscopic approach for GIST of the...
7.
Baron B, Wang Y, Maehara S, Maehara Y, Kuramitsu Y, Nakamura K
Anticancer Res
. 2015 Apr;
35(4):1941-9.
PMID: 25862846
Background/aim: The pancreatic cancer cell line KLM1 can gain chemoresistance following gemcitabine (GEM) treatment. Metformin was found to be a useful sensitising agent towards GEM treatment following gain of chemoresistance....
8.
Baron B, Fujioka T, Kitagawa T, Maehara S, Maehara Y, Nakamura K, et al.
Cancer Genomics Proteomics
. 2015 Mar;
12(2):83-7.
PMID: 25770192
Background: It is known that cancers adopt different strategies to cope with stress and overcome adverse micro-environmental conditions. Such strategies are also applicable to chemo-therapeutic treatment, which could subsequently result...
9.
Wang Y, Kuramitsu Y, Kitagawa T, Baron B, Yoshino S, Maehara S, et al.
Cancer Lett
. 2015 Feb;
360(2):171-6.
PMID: 25684665
Slingshot-1L (SSH1L), a cofilin-phosphatase, plays a role in actin dynamics and cell migration by reactivating cofilin-1. However, the expression of SSH1L in malignant diseases is poorly understood. The overexpression of...
10.
Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, et al.
PLoS One
. 2014 Oct;
9(10):e109076.
PMID: 25271986
Poly (ADP-ribose) polymerase-1 (PARP-1) and autophagy play increasingly important roles in DNA damage repair and cell death. Gemcitabine (GEM) remains the first-line chemotherapeutic drug for pancreatic cancer (PC). However, little...